India, Nov. 16 -- MiniMed (MMED) announced on Monday that the U.S. Food and Drug Administration has cleared MiniMed Fit, the company's first tubeless insulin pump, expanding its automated insulin delivery portfolio.

The system combines up to seven days of wear, a 300-unit insulin capacity, smartphone app control and the company's SmartGuard technology.

Designed for people with Type 1 and Type 2 diabetes aged seven and older, MiniMed Fit automatically adjusts insulin delivery and can provide correction doses every five minutes. It also features Meal Detection technology to deliver additional insulin when a meal dose is missed or underestimated.

googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });

The syste...